Technical Analysis for RKV - Rakovina Therapeutics Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 0.100 | 0.00% | 0.000 |
RKV closed unchanged on Friday, July 26, 2024, on 1.88 times normal volume. It was able to find support at its 50 day moving average. It was able to bounce off of its 200 day moving average, an important long-term support line. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Support | Bullish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 9 hours ago |
| Down 2 ATRs | about 9 hours ago |
| Down 5% | about 9 hours ago |
| Fell Below Lower Bollinger Band | about 9 hours ago |
| Down 1 ATR | about 10 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2024-08-27
Rakovina Therapeutics, Inc., formerly Vincero Capital Corp., is a Canada-based company, which is engaged in developing cancer treatments based on DNA-damage response technologies. The Company’s lead product candidate is kt-2000 Next Generation PARP-inhibitors. Its pipeline includes kt-3000 Dual Action DDR-inhibitors and kt-4000 DNA Damaging DDR-inhibitors. Its kt-2000 series is a patented class of highly potent, oral inhibitors of poly (ADP-ribose) polymerase (PARP). Its kt-3000 drug candidates selectively inhibit secondary DDR pathways associated with treatment resistance and PARP. kt-4000 drug candidates release a potent DNA-damaging agent, while also inhibiting DDR to selectively kill cancer cells.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Catalysts
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Biology Catalysts
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.16 |
| 52 Week Low | 0.005 |
| Average Volume | 31,954 |
| 200-Day Moving Average | 0.095 |
| 50-Day Moving Average | 0.099 |
| 20-Day Moving Average | 0.100 |
| 10-Day Moving Average | 0.100 |
| Average True Range | 0.004 |
| RSI (14) | 52.38 |
| ADX | 19.62 |
| +DI | 20.419 |
| -DI | 60.559 |
| Chandelier Exit (Long, 3 ATRs) | 0.103 |
| Chandelier Exit (Short, 3 ATRs) | 0.097 |
| Upper Bollinger Bands | 0.108 |
| Lower Bollinger Band | 0.092 |
| Percent B (%b) | 0.48 |
| BandWidth | 15.952 |
| MACD Line | 0.000 |
| MACD Signal Line | 0.000 |
| MACD Histogram | -0.0002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.123 | ||||
| Resistance 3 (R3) | 0.120 | 0.110 | 0.119 | ||
| Resistance 2 (R2) | 0.110 | 0.104 | 0.111 | 0.117 | |
| Resistance 1 (R1) | 0.105 | 0.101 | 0.108 | 0.108 | 0.116 |
| Pivot Point | 0.095 | 0.095 | 0.096 | 0.096 | 0.095 |
| Support 1 (S1) | 0.090 | 0.089 | 0.093 | 0.093 | 0.084 |
| Support 2 (S2) | 0.080 | 0.086 | 0.081 | 0.083 | |
| Support 3 (S3) | 0.075 | 0.080 | 0.081 | ||
| Support 4 (S4) | 0.078 |
